文献
J-GLOBAL ID:200902201674583645
整理番号:08A0038683
再発性または難治性多発性骨髄腫の日本人患者におけるプロテアソーム阻害薬ボルテゾミブの第I相および第II相薬物動態/薬力学試験
Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
著者 (15件):
OGAWA Yoshiaki
(Tokai Univ. School of Medicine, Kanagawa)
,
TOBINAI Kensei
(National Cancer Center Hospital, Tokyo)
,
OGURA Michinori
(Aichi Cancer Center, Aichi)
,
ANDO Kiyoshi
(Tokai Univ. School of Medicine, Kanagawa)
,
TSUCHIYA Takahide
(Tokai Univ. School of Medicine, Kanagawa)
,
KOBAYASHI Yukio
(National Cancer Center Hospital, Tokyo)
,
WATANABE Takashi
(National Cancer Center Hospital, Tokyo)
,
MARUYAMA Dai
(National Cancer Center Hospital, Tokyo)
,
MORISHIMA Yasuo
(Aichi Cancer Center, Aichi)
,
KAGAMI Yoshitoyo
(Aichi Cancer Center, Aichi)
,
TAJI Hirofumi
(Aichi Cancer Center, Aichi)
,
MINAMI Hironobu
(National Cancer Center Hospital East, Chiba, JPN)
,
ITOH Kuniaki
(National Cancer Center Hospital East, Chiba, JPN)
,
NAKATA Masanobu
(National Cancer Center Hospital East, Chiba, JPN)
,
HOTTA Tomomitsu
(Tokai Univ. School of Medicine, Kanagawa)
資料名:
Cancer Science
(Cancer Science)
巻:
99
号:
1
ページ:
140-144
発行年:
2008年01月
JST資料番号:
W1423A
ISSN:
1347-9032
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オーストラリア (AUS)
言語:
英語 (EN)